Mycosis Fungoides

• CLINICAL_TRIALS withdrawal · 2025-06-27
  Clinical Trial Update: BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma [Phase 1, Phase 2]

  A phase 1/2 clinical trial evaluating cemiplimab for advanced cutaneous T-cell lymphoma (Mycosis fungoides) has been withdrawn (NCT05538988)…

• CLINICAL_TRIALS withdrawal · 2025-06-12
  Clinical Trial Update: Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. [NA]

  A clinical trial evaluating Triamcinolone acetonide injections with a novel needle-free delivery system for primary cutaneous lymphoma plaqu…

• CLINICAL_TRIALS withdrawal · 2025-05-02
  Clinical Trial Update: Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma [Phase 1]

  A Phase 1 trial evaluating reduced-intensity conditioning before a partially matched donor stem cell transplant for advanced cutaneous T-cel…

• CLINICAL_TRIALS withdrawal · 2025-04-29
  Clinical Trial Update: Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides [Phase 2]

  A Phase 2 trial evaluating low-dose total skin electron beam radiation therapy with mechlorethamine hydrochloride gel for Mycosis Fungoides …

• CLINICAL_TRIALS withdrawal · 2016-12-01
  Clinical Trial Update: Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides. [Phase 1, Phase 2]

  A Phase I/II study of intratumoral CPG 7909 (TLR9 agonist) with local radiation for recurrent mycosis fungoides has been withdrawn.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.